Spotlight on CYP4B1

被引:5
|
作者
Roeder, Annika [1 ]
Huesken, Saskia [2 ]
Hutter, Michael C. [3 ]
Rettie, Allan E. [4 ]
Hanenberg, Helmut [2 ,5 ]
Wiek, Constanze [2 ]
Girhard, Marco [1 ]
机构
[1] Heinrich Heine Univ, Inst Biochem, D-40225 Dusseldorf, Germany
[2] Heinrich Heine Univ, Dept Otorhinolaryngol & Head Neck Surg, D-40225 Dusseldorf, Germany
[3] Saarland Univ, Ctr Bioinformat, D-66123 Saarbrucken, Germany
[4] Univ Washington, Sch Pharm, Dept Med Chem, Seattle, WA 98105 USA
[5] Univ Duisburg Essen, Univ Childrens Hosp Essen, Dept Pediatr 3, D-45147 Essen, Germany
关键词
cytochrome P450; structure; bioactivation; xenobiotics; drug metabolism; endobiotic metabolism; cancer; suicide gene; DAMAGED SWEET-POTATOES; COVALENT HEME-BINDING; METABOLIC-ACTIVATION; CYTOCHROME-P450; 4B1; 20-HYDROXYEICOSATETRAENOIC ACID; PERILLA KETONE; SUICIDE GENE; LUNG-CANCER; MUTAGENIC ACTIVATION; BLADDER CARCINOGENS;
D O I
10.3390/ijms24032038
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The mammalian cytochrome P450 monooxygenase CYP4B1 can bioactivate a wide range of xenobiotics, such as its defining/hallmark substrate 4-ipomeanol leading to tissue-specific toxicities. Similar to other members of the CYP4 family, CYP4B1 has the ability to hydroxylate fatty acids and fatty alcohols. Structural insights into the enigmatic role of CYP4B1 with functions in both, xenobiotic and endobiotic metabolism, as well as its unusual heme-binding characteristics are now possible by the recently solved crystal structures of native rabbit CYP4B1 and the p.E310A variant. Importantly, CYP4B1 does not play a major role in hepatic P450-catalyzed phase I drug metabolism due to its predominant extra-hepatic expression, mainly in the lung. In addition, no catalytic activity of human CYP4B1 has been observed owing to a unique substitution of an evolutionary strongly conserved proline 427 to serine. Nevertheless, association of CYP4B1 expression patterns with various cancers and potential roles in cancer development have been reported for the human enzyme. This review will summarize the current status of CYP4B1 research with a spotlight on its roles in the metabolism of endogenous and exogenous compounds, structural properties, and cancer association, as well as its potential application in suicide gene approaches for targeted cancer therapy.
引用
收藏
页数:21
相关论文
共 50 条
  • [21] Expression profile of CYP1A1 and CYP1B1 enzymes in endometrial tumors
    Spyrou, Ioannis
    Sifakis, Stavros
    Ploumidis, Achilles
    Papalampros, Alexandros E.
    Felekouras, Evangellos
    Tsatsakis, Aristidis M.
    Spandidos, Demetrios A.
    Androutsopoulos, Vasilis P.
    TUMOR BIOLOGY, 2014, 35 (10) : 9549 - 9556
  • [22] In vitro biotransformation of imatinib by the tumor expressed CYP1A1 and CYP1B1
    Rochat, Bertrand
    Zoete, Vincent
    Grosdidier, Aurelien
    von Gruenigen, Sandrine
    Marull, Marc
    Michielin, Olivier
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2008, 29 (02) : 103 - 118
  • [23] Protein expression of CYP1A1, CYP1B1, ALDH1A1, and ALDH2 in young patients with oral squamous cell carcinoma
    Kaminagakura, E.
    Caris, A.
    Coutinho-Camillo, C.
    Soares, F. A.
    Takahama-Junior, A.
    Kowalski, L. P.
    INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2016, 45 (06) : 706 - 712
  • [24] 4-Phenylcoumarins from Mesua ferrea with selective CYP1B1 inhibitory activity
    Zhou, Fengxu
    Huang, Ruoyue
    Cao, Tingting
    Liu, Jia
    Yang, Weimin
    Li, Fei
    Li, Xian
    MEDICINAL CHEMISTRY RESEARCH, 2022, 31 (12) : 2172 - 2181
  • [25] Cytochrome P1B1 (CYP1B1) polymorphisms and cancer risk: A meta-analysis of 52 studies
    Li, Cuiping
    Long, Bingshuang
    Qin, Xianjing
    Li, Weixiong
    Zhou, Yang
    TOXICOLOGY, 2015, 327 : 77 - 86
  • [26] Expression Profile of CYP1A1 and CYP1B1 Enzymes in Colon and Bladder Tumors
    Androutsopoulos, Vasilis P.
    Spyrou, Ioannis
    Ploumidis, Achilles
    Papalampros, Alexandros Eystathios
    Kyriakakis, Michalis
    Delakas, Demetrios
    Spandidos, Demetrios A.
    Tsatsakis, Aristidis M.
    PLOS ONE, 2013, 8 (12):
  • [27] Analysis of CYP3A4*1B and CYP3A5*3 polymorphisms in population of Bosnia and Herzegovina
    Semiz, Sabina
    Dujic, Tanja
    Ostanek, Barbara
    Prnjavorac, Besim
    Bego, Tamer
    Malenica, Maja
    Mlinar, Barbara
    Marc, Janja
    Causevic, Adlija
    MEDICINSKI GLASNIK, 2011, 8 (01) : 84 - 89
  • [28] The Activation of Procarcinogens by CYP1A1/1B1 and Related Chemo-Preventive Agents: A Review
    Li, Yubei
    Cui, Jiahua
    Jia, Jinping
    CURRENT CANCER DRUG TARGETS, 2021, 21 (01) : 21 - 54
  • [29] CYP1A1 *2B and *4 polymorphisms are associated with lung cancer susceptibility in Mexican patients
    Gallegos-Arreola, M. P.
    Figuera-Villanueva, L. E.
    Troyo-Sanroman, R.
    Morgan-Villela, G.
    Puebla-Perez, A. M.
    Flores-Marquez, M. R.
    Zuniga-Gonzalez, G. M.
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2008, 23 (01) : 24 - 30
  • [30] CYP1B1: A Unique Gene with Unique Characteristics
    Faiq, Muneeb A.
    Dada, Rima
    Sharma, Reetika
    Saluja, Daman
    Dada, Tanuj
    CURRENT DRUG METABOLISM, 2014, 15 (09) : 893 - 914